Blood Purification Device Removes Inflammatory Cytokines with Jim Joyce Sigyn Therapeutics TRANSCRIPT
Download PDFJul 27, 2021
Jim Joyce is the Co-Founder, Chairman, and CEO of Sigyn Therapeutics, and we talk about removing inflammatory targets from the bloodstream with advanced blood purification technology.
Jim says, "The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of...
Jul 27, 2021
Jim Joyce is the Co-Founder, Chairman, and CEO of Sigyn Therapeutics, and we talk about removing inflammatory targets from the bloodstream with advanced blood purification technology.
Jim says, "The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of...
Developing Nasal Sprays for Temporary Protection Against Existing and New Respiratory Viruses with Koenraad Wiedhaup Leyden Labs TRANSCRIPT
Download PDFJul 20, 2021
Koenraad Wiedhaup, Founder and CEO of Leyden Labs, and his team have taken a proactive approach to overcome the challenges of protecting people from known viruses and new viruses. They are developing intranasal sprays containing biological molecules that can temporarily protect against a broad range of viruses. This...
Jul 20, 2021
Koenraad Wiedhaup, Founder and CEO of Leyden Labs, and his team have taken a proactive approach to overcome the challenges of protecting people from known viruses and new viruses. They are developing intranasal sprays containing biological molecules that can temporarily protect against a broad range of viruses. This...
Mar 30, 2020
Greg Merril, CEO, Adaptive Phage Therapeutics describes useful viruses that host on and kill bacteria acting as nature's natural antibiotic. Phage therapy actually predates antibiotics but recent research has enabled scientist to better identify which phage will have the desired impact on specific bacteria. Greg talks...